Amber N. O'Bryan

Amber N. O’Bryan serves as a key procurement professional within the Naval Medical Logistics Command, supporting the Department of Defense’s mission to sustain combat-ready medical forces through the acquisition of advanced diagnostic equipment, laboratory systems, and life-sustaining medical supplies. She manages a portfolio of complex contracts focused on ensuring operational medical readiness across global theaters, with an emphasis on point-of-care diagnostics, analytical instrumentation, and clinical research support. Her acquisitions are mission-critical, enabling rapid clinical decision-making in austere environments and reinforcing the Navy and Marine Corps’ ability to deliver high-acuity care under dynamic conditions. O’Bryan maintains strategic partnerships with manufacturers and research firms specializing in medical laboratory instrumentation and physical sciences R&D. While no specific contractors are currently identified in the award record, her procurement patterns indicate consistent engagement with high-technology vendors capable of delivering FDA-cleared, military-specification medical devices and calibrated analytical systems. Her working relationships emphasize technical compliance, supply chain resilience, and rapid delivery timelines, reflecting the urgency of expeditionary medical operations. Her contracting activity shows a 100% preference for open, unrestricted competitions, with no use of 8(a), HUBZone, SDVOSB, or other socioeconomic set-asides. This reflects a mission-driven prioritization of technical capability and operational readiness over socioeconomic preferences, though small businesses remain eligible and competitive within open solicitations. Her primary NAICS focus areas—621511 (Medical Laboratories) and 334516 (Analytical Laboratory Instrument Manufacturing)—reveal deep expertise in procuring clinical diagnostic systems, automated lab analyzers, and precision testing equipment. An additional focus on 541712 (R&D in Life Sciences) underscores her involvement in next-generation medical technologies, including field-deployable diagnostic platforms and advanced biosensing tools critical to modern combat medicine.